Skip to main content

ETF comparison

FHLC vs IXJ

Both Healthcare.

Fidelity MSCI Health Care Index ETF · iShares Global Healthcare ETF

Holdings overlap

Weighted by ISIN/CUSIP
70.9 %

60 positions appear in both funds. Buying equal dollars of FHLC and IXJ would leave roughly 70.9% of each dollar exposed to the same underlying securities.

FHLC unmatched 28.9% Shared 70.9% IXJ unmatched 28.7%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In FHLC only
274 positions
Shared
60 positions
In IXJ only
50 positions

Side by side

FHLC

Fidelity MSCI Health Care Index ETF

Fidelity · Healthcare

79 composite / 100
Expense ratio
0.084%
Net assets
$3.54B
TTM yield
1.18%
Top-10 conc.
51.9%
IXJ

iShares Global Healthcare ETF

iShares · Healthcare

69 composite / 100
Expense ratio
0.38%
Net assets
$4.32B
TTM yield
1.32%
Top-10 conc.
47.8%

Sub-score comparison

92
Cost
62
83
Tax efficiency
83
80
Liquidity
84
40
Concentration
46
—
Tracking quality
—
FHLC sub-score IXJ

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

FHLC is 30 bps cheaper than IXJ. On a $100,000 position that's about $296/yr more in fees for IXJ.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with FHLC vs IXJ.

Top shared holdings

60 shared in total
# Holding In FHLC In IXJ Overlap
1 Eli Lilly & Co 13.35% 10.93% 10.93%
2 Johnson & Johnson 8.93% 7.04% 7.04%
3 AbbVie Inc 6.42% 5.12% 5.12%
4 UnitedHealth Group Inc 5.44% 4.40% 4.40%
5 Merck & Co Inc 4.66% 4.12% 4.12%
6 Amgen Inc 3.00% 2.54% 2.54%
7 Thermo Fisher Scientific Inc 3.09% 2.42% 2.42%
8 Abbott Laboratories 2.66% 2.05% 2.05%
9 Gilead Sciences Inc 2.34% 2.04% 2.04%
10 Intuitive Surgical Inc 1.82% 1.83% 1.82%
11 Pfizer Inc 2.06% 1.78% 1.78%
12 CVS Health Corp 1.92% 1.71% 1.71%

Only in FHLC

274 total
  • Natera Inc 0.52%
  • Illumina Inc 0.44%
  • Revolution Medicines Inc 0.44%
  • Alnylam Pharmaceuticals Inc 0.39%
  • Royalty Pharma PLC 0.35%
  • Tenet Healthcare Corp 0.32%
  • Insmed Inc 0.30%
  • United Therapeutics Corp 0.30%
  • Guardant Health Inc 0.28%
  • Neurocrine Biosciences Inc 0.23%

Only in IXJ

50 total
  • ASTRAZENECA PLC 3.76%
  • Roche Holding AG 3.75%
  • Novartis AG 3.71%
  • NOVO NORDISK A/S 1.99%
  • GSK PLC 1.38%
  • SANOFI SA 1.18%
  • argenx SE 0.74%
  • ESSILORLUXOTTICA SA 0.71%
  • Bayer Aktiengesellschaft 0.71%
  • HOYA CORPORATION 0.70%

Percentages are holdings overlap with the named fund.

Open FHLC or IXJ at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.